We are live on ! Find out more
PTP

Platform Technology Partners Portfolio holdings

AUM $611M
1-Year Est. Return 25.5%
This Fund
S&P 500
This Quarter Est. Return
+14.68%
1 Year Est. Return
+25.5%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$205M
AUM Growth
+$41.7M
Cap. Flow
+$21.9M
Cap. Flow %
10.68%
Top 10 Hldgs %
32.31%
Holding
252
New
49
Increased
110
Reduced
51
Closed
10

Top Sells

Rank Stock Value
1
RTN
Raytheon Company
RTN
+$834K
2
ATER icon
Aterian
ATER
+$667K
3
NFLX icon
Netflix
NFLX
+$542K
4
GILD icon
Gilead Sciences
GILD
+$312K
5
ULTA icon
Ulta Beauty
ULTA
+$248K

Sector Composition

Rank Sector Weight
1 Technology 20.25%
2 Healthcare 11.12%
3 Financials 10.12%
4 Consumer Discretionary 10.1%
5 Communication Services 8.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NSL
226
DELISTED
NUVEEN SENIOR INCM FD
NSL
$53K 0.03%
10,125
RRD
227
DELISTED
RR Donnelley & Sons Co.
RRD
$51K 0.02%
+22,400
New +$33.7K
AMC icon
228
AMC Entertainment Holdings
AMC
$2.03B
$49K 0.02%
+2,300
New +$75.2K
TXMD icon
229
TherapeuticsMD
TXMD
$24M
$48K 0.02%
800
-100
-11% -$6.83K
ABEO icon
230
Abeona Therapeutics
ABEO
$345M
$43K 0.02%
1,108
+288
+35% +$9.81K
GERN icon
231
Geron
GERN
$924M
$41K 0.02%
+26,100
New +$47.5K
VXX icon
232
CALL
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
$161M
$41K 0.02%
+313
New +$407K
DCOY
233
Decoy Therapeutics
DCOY
$2.57M
$36K 0.02%
+1
New +$29.3K
XCUR icon
234
Exicure
XCUR
$11M
$32K 0.02%
120
UVXY icon
235
CALL
ProShares Ultra VIX Short-Term Futures ETF
UVXY
$248M
$26K 0.01%
+12
New +$437K
EVFM
236
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$24K 0.01%
+667
New +$24.1K
LYG icon
237
Lloyds Banking Group
LYG
$87.5B
$22K 0.01%
11,212
-5,508
-33% -$9.28K
DARE icon
238
Dare Bioscience
DARE
$19.2M
$20K 0.01%
+1,250
New +$17.5K
NCLH icon
239
CALL
Norwegian Cruise Line
NCLH
$8.9B
$12K 0.01%
+4,000
New +$83.5K
NIO icon
240
CALL
NIO
NIO
$11.2B
$9K ﹤0.01%
+1,500
New +$58K
DKNG icon
241
CALL
DraftKings
DKNG
$11.4B
$8K ﹤0.01%
+4,000
New +$190K
BMY.RT
242
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$8K ﹤0.01%
11,333
-950
-8% -$2.02K
FXA icon
243
PUT
Invesco CurrencyShares Australian Dollar Trust
FXA
$96.8M
-10,500
Closed -$9K
GILD icon
244
Gilead Sciences
GILD
$161B
-4,937
Closed -$312K
LMT icon
245
Lockheed Martin
LMT
$134B
-550
Closed -$211K
NFLX icon
246
Netflix
NFLX
$292B
-10,840
Closed -$542K
PID icon
247
Invesco International Dividend Achievers ETF
PID
$913M
-11,900
Closed -$151K
ULTA icon
248
Ulta Beauty
ULTA
$20.4B
-1,107
Closed -$248K
VBIV
249
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
-393
Closed -$34K
FEAC.WS
250
DELISTED
Flying Eagle Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A com
FEAC.WS
-18,335
Closed -$60K

Similar funds

Platform Technology Partners's Q4 2020 Portfolio in Review

As of Q4 2020, Platform Technology Partners held 252 positions worth $205M, up 26% from $163M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Platform Technology Partners deployed $21.9M of net new capital in Q4 2020, opening 49 new positions and adding to 110 existing holdings. Its largest new stake was iShares Core S&P 500 ETF: 6,981 shares worth $2.62M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Aterian, an estimated $667K trimmed.

  • Platform Technology Partners's largest Q4 2020 buy was iShares Core S&P 500 ETF: 6,981 shares worth $2.62M.
  • Platform Technology Partners added most to Schwab US Dividend Equity ETF in Q4 2020, an estimated $1.36M increase.
  • Platform Technology Partners's biggest Q4 2020 reduction was Aterian, cutting an estimated $667K.
  • Platform Technology Partners fully exited Raytheon Company in Q4 2020, selling an estimated $834K.
  • Platform Technology Partners's ten largest holdings make up 32% of its $205M portfolio in Q4 2020.
  • Platform Technology Partners opened 49 new positions and closed 10 in Q4 2020.
  • Platform Technology Partners's portfolio value rose 26% quarter-over-quarter to $205M.

Based on Platform Technology Partners's 13F filing for Q4 2020, filed 9 Feb 2021.